Clinical and Pathological Characteristics of Autoimmune Hepatitis with Acute Presentation

Table 4

Comparison of treatments between A-AIH and C-AIH before liver biopsy.

	Acute; (40.0%)	Chronic; (60.0%)
No treatment	1 (3.1%)	6 (12.5%)	0.078
General treatment	21 (65.6%)	31 (64.6%)
General treatment + immunosuppressants	1 (3.1%)	5 (10.4%)
General treatment + UDCA	8 (25%)	3 (6.3%)
General treatment + immunosuppressants + UDCA	1 (3.1%)	3 (6.3%)
Time of treatment (months)	2 (0.50, 12)	1 (0.33, 12)	0.805